Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ethenzamide is a small molecule non-opioid analgesic and anti-inflammatory drug used for the relief of pain (including headache and toothache), fever, and other minor aches. It is commonly available as an over-the-counter medication in East Asia—especially Japan—where it is often found in combination with caffeine and acetaminophen for indications such as headache, menstrual cramps, toothache, and fever[1][3][7]. Ethenzamide acts primarily via antagonism of the 5-hydroxytryptamine (serotonin) 2B receptor (5HT2B), with additional modest inhibitory effects on monoamine oxidase-A and transient receptor potential vanilloid 1 channel; it does not inhibit cyclooxygenase-1 or -2[6][8]. In vivo it is metabolized to salicylamide[3]. It has been used both alone and in combination with other NSAIDs for symptomatic relief of cold symptoms[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ethenzamide.